Loading clinical trials...
Loading clinical trials...
We wish to find out if in non-diabetic pregnancies, as well as diabetic pregnancies, additional data obtained by Continuous Glucose Monitoring improves perinatal risk prediction.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Stanford University
Collaborators
NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more
NCT07286747 · Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
NCT00001987 · Diabetes Mellitus, Severe Insulin Resistance
NCT07483723 · Polycystic Ovary Syndrome, Glucose Profile, and more
NCT07460856 · Overweight/Obesity, Metabolic Syndrome, and more
Stanford University School of Medicine
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions